| Literature DB >> 36231007 |
Xiao Ding1,2, Lu Yu2, Luo Chen2, Yujie Li2, Jinlun Zhang2, Hanyan Sheng2, Zhengwei Ren2, Yunlong Li2, Xiaohan Yu2, Shuangxia Jin2, Jinglin Cao3.
Abstract
Genome editing technology has become one of the hottest research areas in recent years. Among diverse genome editing tools, the Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated proteins system (CRISPR/Cas system) has exhibited the obvious advantages of specificity, simplicity, and flexibility over any previous genome editing system. In addition, the emergence of Cas9 mutants, such as dCas9 (dead Cas9), which lost its endonuclease activity but maintains DNA recognition activity with the guide RNA, provides powerful genetic manipulation tools. In particular, combining the dCas9 protein and transcriptional activator to achieve specific regulation of gene expression has made important contributions to biotechnology in medical research as well as agriculture. CRISPR/dCas9 activation (CRISPRa) can increase the transcription of endogenous genes. Overexpression of foreign genes by traditional transgenic technology in plant cells is the routine method to verify gene function by elevating genes transcription. One of the main limitations of the overexpression is the vector capacity constraint that makes it difficult to express multiple genes using the typical Ti plasmid vectors from Agrobacterium. The CRISPRa system can overcome these limitations of the traditional gene overexpression method and achieve multiple gene activation by simply designating several guide RNAs in one vector. This review summarizes the latest progress based on the development of CRISPRa systems, including SunTag, dCas9-VPR, dCas9-TV, scRNA, SAM, and CRISPR-Act and their applications in plants. Furthermore, limitations, challenges of current CRISPRa systems and future prospective applications are also discussed.Entities:
Keywords: CRISPR/Cas; CRISPRa; dCas9; genome editing; transcription activation
Mesh:
Substances:
Year: 2022 PMID: 36231007 PMCID: PMC9564188 DOI: 10.3390/cells11193045
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Figure 1Characteristics of different types of CRISPR/Cas systems. CRISPR/Cas systems are classified as types I to VI. Type I systems are characterized based on the occurrence of signature protein Cas3, a protein which contains both DNase and helicase domains used to degrade the target. Type II CRISPR/Cas systems use Cas1, Cas2, Cas9, and a fourth protein (Csn2 or Cas4), whereas the type III CRISPR/Cas systems comprise the Cas10 with an indistinct role. The type II CRISPR/Cas system originates from S. pyogenes and comprises three components: the CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and a Cas9 protein. The type V CRISPR/Cas system (Cas12) is an RNA-guided system which is analogous to CRISPR/Cas9 but exhibits some unique characteristics. This CRISPR system relies on a T-rich sequence at the 5′-end of the protospacer sequence (5′-TTTN-3′ or 5′-TTTV-3′; V = A, C, or G, in some cases), as opposed to the G-rich, NGG sequence for Cas9. The type VI system (Cas13) is effector protein for RNA cutting, which is used as RNA-guided ribonuclease, the nonspecific, trans-acting RNase activity of which is activated by base pairing of the crRNA guide to an ssRNA target. The Cas7, Cas5,SS*, Cas8(LS), Cas10 and CSf1(LS) have been drew with different colors, but they all belong to interference part of class I.
Applications of CRISPR interference in plants.
| Repressor | Plant Species | Target Gene | Highest Repression | References |
|---|---|---|---|---|
| dCas9 |
|
| 20 | (Piatek et al., 2015) |
| 80 | (Vazquez-Vilar et al., 2016) | |||
| dCas9-SRDX |
|
| 33 | (Piatek et al., 2015) |
| 50 | (Vazquez-Vilar et al., 2016) | |||
|
|
| 75 | (Irene et al., 2020) | |
|
|
| 60 | ||
| dCas9-BRD |
| 60 | (Vazquez-Vilar et al., 2016) | |
| dCas9-3 × SRDX |
|
| 60 | (Lowder et al., 2015) |
|
| 80 | |||
|
| 70 | |||
| dLbCpf1-SRDX |
|
| 90 | (Tang et al., 2017) |
| dAsCpf1-SRDX |
|
| 90 |
Figure 2The diagram of CRISPR/dCas9-mediated transcriptional regulation. The dCas9 fused with transcriptional inhibitors or activators can provide additional inhibition (CRISPRi) or activation (CRISPRa) functions.
Applications of the CRISPR-activation system in plants.
| Activator | Plant Species | Target Gene | Fold Change | References |
|---|---|---|---|---|
| dCas9-EDLL |
|
| 3.5 | (Piatek et al., 2015) |
| 2.2 | (Vazquez-vilar et al., 2016) | |||
| dCas9-TAL |
|
| 4 | (Piatek et al., 2015) |
| dCas9-VP64 |
|
| 7 | (Lowder et al., 2015) |
|
| 7.5 | |||
|
| 400 | |||
|
| 2.3 | (Vazquez-vilar et al., 2016) | ||
|
|
| 2.1 | (Li et al., 2017) | |
|
| 0.9 | |||
|
| 4.3 | |||
|
|
| 2.7 | ||
|
| 0.3 | |||
|
| 2.1 | (Lowder et al., 2018) | ||
|
| 1.1 | |||
|
| 2.2 | |||
|
|
| 2.5 | (Irene et al., 2020) | |
|
| 2.0 | |||
| dCas9-VP64 + MS2-p65-HSF1 (SAM) |
|
| 5 | (Park et al., 2017) |
|
| 7 | |||
| dCas9-4 × EE-2 × VP64 |
| 12.6 | (Li et al., 2017) | |
| dCas9-6 × TAL-2 × VP64 (dCas9-TV) |
|
| 138.8 | (Li et al., 2017) |
|
| 32.3 | |||
|
| 92.2 | |||
|
|
| 78.8 | ||
|
| 62 | |||
| dCpf1-TV |
| 4.7 | (Li et al., 2017) | |
| dCas9-VP64-EDLL |
|
| 4 | (Lowder et al., 2018) |
|
| 3 | |||
|
|
| 5 | (Lee et al., 2021) | |
| dCas9-VP64 + MS2-EDLL |
|
| 30 | (Lowder et al., 2018) |
|
| 30 | |||
| dCas9-VP64 + MS2-VP64 |
|
| 45 | (Lowder et al., 2018) |
|
| 1500 | |||
|
| 40 | |||
|
| 6 | |||
|
|
| 3 | ||
|
| 4 | |||
|
| 2.8 | |||
| dCas9-2 × GCN4 + scFv-sfGFP-VP64 (SunTag) |
|
| 140 | (Papikian et al., 2019) |
|
| 4000 | |||
|
| 350 | |||
|
| 130 | |||
| dCasEV2.1 |
| NbAN2 | 4000 | (Selma et al., 2019) |
| NbDFR | 10000 | |||
| NbPAL | 400 | (Selma et al., 2022) | ||
| NbC4H | 4 | |||
| Nb4CL | 15 | |||
| NbCHS | 18000 | |||
| NbCHI | 45 | |||
| NbF3H | 140 | |||
| NbFLS | 40 | |||
| dCas9-TV |
|
| 4000 | (Xiong et al., 2021) |
|
|
| 41.7 | (unpublished data) | |
|
| 16 | |||
| CRISPR-Act3.0 |
|
| 45 | (Pan et al., 2021) |
|
| 90 | |||
| CRISPR-Act3.0 |
| 70 | ||
|
| 95 | |||
| CRISPR-Act3.0 |
| 45 | ||
|
| 40 | |||
| CRISPR-Act3.0 |
| 15 | ||
|
| 10 | |||
| CRISPR-Act3.0 |
| 30 | ||
| CRISPR-Act3.0 | 90 | |||
| CRISPR-Act3.0 | 140 | |||
| CRISPR-Act3.0 | 250 | |||
| CRISPR-Act3.0 | 120 | |||
| CRISPR-Act3.0 | 50 | |||
| CRISPR-Act3.0 | 35 | |||
| CRISPR-Act3.0 | 25 | |||
| CRISPR-Act3.0 | 30 | |||
| CRISPR-Act3.0 | 45 | |||
| M-Act3.0 |
| 9 | ||
|
| 6 | |||
|
| 17 | |||
|
| 3 | |||
|
| 23 | |||
|
| 3.5 | |||
|
| 11 | |||
|
| 30 | |||
|
| 2 | |||
|
| 130 | |||
|
| 20 | |||
|
| 70 | |||
|
|
| 240 | ||
|
| 8 | |||
|
| 4000 | |||
|
| 350 | |||
|
| 130 | |||
|
|
| 240 |
Figure 3Schematic diagram of CRISPR transcriptional regulation. (A) SunTag system: dCas9 fused with GCN4 to recruit multiple copies of scFv, TET and other element X to activate the target gene cooperatively; (B) dCas9-VPR system: dCas9 fused with VP64-p65-Rta to activate the target gene; (C) dCas9-TV system: dCas9 TV activation system includes 6 TAL and 2 VP128; (D) scRNA system: An RNA hairpin domain with RNA sequences MS2, PP7 and com recognized by MCP, PCP and com RNA binding proteins was introduced at the end of sgRNA, and the transcription activating element VP64 was fused into each corresponding RNA binding protein; (E) SAM system: The four bases at the distal end of the stem loops of gRNA were modified to recognize the stem loops of MS2 to bind p65 and HSF1; (F) CRISPR-Act2.0 system: dCas9 was fused with VP64 and the four bases at the distal end of the stem loops of gRNA were modified to recognize the stem loops of MS2 to bind VP64; (G) CRISPR-Act3.0 system: SunTag system with the MS2–MCP interaction would recruit more activator.